Literature DB >> 29928179

Necrotizing Enterocolitis in Two Siblings and an Unrelated Infant with Overlapping Chromosome 6q25 Deletions.

Hannah C D Esdal1, Muhammad B Ghbeis2, Daniel A Saltzman3, Donavon Hess3, Janet R Hume4, Robyn C Reed5, Susan A Berry6, Eric Hoggard7, Betsy Hirsch8, Linda B Baughn9, Lisa A Schimmenti10.   

Abstract

The pathogenesis of necrotizing enterocolitis (NEC) remains poorly understood but is thought to be multifactorial. There are no specific recurring chromosomal abnormalities previously associated with NEC. We report 3 cases of intestinal necrosis associated with large chromosome 6 deletions. The first patient was found to have a 7.9-Mb deletion of chromosome 6 encompassing over 40 genes, arr[GRCh37] 6q25.3q26(155699183_163554531)×1. The second patient had a 19.5-Mb deletion of chromosome 6 generated by an unbalanced translocation with chromosome 18, 46,XY,der(6)t (6;18)(q25.1;p11.23), arr[GRCh37] 6q25.1q27(151639526_ 171115067)×1, 18p11.32p11.23(131700_7694199)×3, which included the whole 7.9-Mb region deleted in the first patient. The third patient was the younger sibling of the second patient with an identical derivative chromosome 6. The shared abnormal chromosome 6 region includes multiple genes of interest, particularly EZR. Mouse models have demonstrated that Ezr is expressed in microvillar epithelium and helps regulate cell-cell adhesion in the gut. We hypothesize that deletion of this shared region of 6q leads to gastrointestinal vulnerability which may predispose patients to intestinal necrosis.

Entities:  

Keywords:  Chromosome 6q deletion; EZR; Necrotizing enterocolitis

Year:  2018        PMID: 29928179      PMCID: PMC6006637          DOI: 10.1159/000488817

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  36 in total

1.  Interstitial 6q25 microdeletion syndrome: ARID1B is the key gene.

Authors:  Luisa Ronzoni; Francesco Tagliaferri; Arianna Tucci; Marco Baccarin; Susanna Esposito; Donatella Milani
Journal:  Am J Med Genet A       Date:  2016-01-11       Impact factor: 2.802

2.  Interstitial deletion of 6q25.2-q25.3: a novel microdeletion syndrome associated with microcephaly, developmental delay, dysmorphic features and hearing loss.

Authors:  Sandesh Chakravarthy Sreenath Nagamani; Ayelet Erez; Christine Eng; Zhishuo Ou; Craig Chinault; Laura Workman; James Coldwell; Pawel Stankiewicz; Ankita Patel; James R Lupski; Sau Wai Cheung
Journal:  Eur J Hum Genet       Date:  2008-11-26       Impact factor: 4.246

3.  Association of celiac disease genes with inflammatory bowel disease in Finnish and Swedish patients.

Authors:  A S Parmar; M Lappalainen; P Paavola-Sakki; L Halme; M Färkkilä; U Turunen; K Kontula; A Aromaa; V Salomaa; L Peltonen; J Halfvarson; L Törkvist; M D'Amato; P Saavalainen; E Einarsdottir
Journal:  Genes Immun       Date:  2012-05-17       Impact factor: 2.676

4.  6q terminal deletion syndrome associated with a distinctive EEG and clinical pattern: a report of five cases.

Authors:  Maurizio Elia; Pasquale Striano; Marco Fichera; Roberto Gaggero; Lucia Castiglia; Ornella Galesi; Michela Malacarne; Mauro Pierluigi; Carmelo Amato; Sebastiano A Musumeci; Corrado Romano; Silvia Majore; Paola Grammatico; Federico Zara; Salvatore Striano; Francesca Faravelli
Journal:  Epilepsia       Date:  2006-05       Impact factor: 5.864

5.  Overlapping genetic susceptibility variants between three autoimmune disorders: rheumatoid arthritis, type 1 diabetes and coeliac disease.

Authors:  Stephen Eyre; Anne Hinks; John Bowes; Edward Flynn; Paul Martin; Anthony G Wilson; Ann W Morgan; Paul Emery; Sophia Steer; Lynne J Hocking; David M Reid; Pille Harrison; Paul Wordsworth; Wendy Thomson; Jane Worthington; Anne Barton
Journal:  Arthritis Res Ther       Date:  2010-09-20       Impact factor: 5.156

6.  Inhibition of RAS activation due to a homozygous ezrin variant in patients with profound intellectual disability.

Authors:  Lars Björn Riecken; Hasan Tawamie; Carsten Dornblut; Rebecca Buchert; Amina Ismayel; Alexander Schulz; Johannes Schumacher; Heinrich Sticht; Katja J Pohl; Yan Cui; André Reis; Helen Morrison; Rami Abou Jamra
Journal:  Hum Mutat       Date:  2015-02       Impact factor: 4.878

7.  T-cell activation Rho GTPase-activating protein expression varies with inflammation location and severity in Crohn's disease.

Authors:  Tara M Connelly; Arthur S Berg; Leonard R Harris; John P Hegarty; Francesca M Ruggiero; Susan M Deiling; David L Brinton; Walter A Koltun
Journal:  J Surg Res       Date:  2014-01-17       Impact factor: 2.192

8.  Moesin functions antagonistically to the Rho pathway to maintain epithelial integrity.

Authors:  Olga Speck; Sarah C Hughes; Nicole K Noren; Rima M Kulikauskas; Richard G Fehon
Journal:  Nature       Date:  2003-01-02       Impact factor: 49.962

9.  Periventricular heterotopia in 6q terminal deletion syndrome: role of the C6orf70 gene.

Authors:  Valerio Conti; Aurelie Carabalona; Emilie Pallesi-Pocachard; Elena Parrini; Richard J Leventer; Emmanuelle Buhler; George McGillivray; François J Michel; Pasquale Striano; Davide Mei; Françoise Watrin; Stefano Lise; Alistair T Pagnamenta; Jenny C Taylor; Usha Kini; Jill Clayton-Smith; Francesca Novara; Orsetta Zuffardi; William B Dobyns; Ingrid E Scheffer; Stephen P Robertson; Samuel F Berkovic; Alfonso Represa; David A Keays; Carlos Cardoso; Renzo Guerrini
Journal:  Brain       Date:  2013-09-20       Impact factor: 13.501

10.  A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites.

Authors:  N Sato; N Funayama; A Nagafuchi; S Yonemura; S Tsukita; S Tsukita
Journal:  J Cell Sci       Date:  1992-09       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.